Epidemiologic and clinical features of cyanobacteria harmful algal bloom exposures reported to the National Poison Data System, United States, 2010-2022: a descriptive analysis.


Journal

Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645

Informations de publication

Date de publication:
05 Oct 2024
Historique:
received: 27 06 2024
accepted: 27 09 2024
medline: 6 10 2024
pubmed: 6 10 2024
entrez: 5 10 2024
Statut: epublish

Résumé

Harmful algal bloom occurrences have been increasingly reported globally and over time. Exposure to the variety of toxins and co-contaminants that may be present in harmful algal blooms can cause illness and even death. Poison control data is a valuable public health information source that has been used to characterize many types of toxin exposures, including harmful algal blooms. Prior studies have been limited by location and time, and knowledge gaps remain regarding cyanobacteria harmful algal bloom (cyanoHAB) exposure circumstances, and the breadth and severity of associated clinical effect. The objective of this study was to characterize epidemiologic and clinical features of cyanoHAB exposure cases reported to 55 US poison control centers and available in the National Poison Data System (NPDS). We identified 4260 NPDS cyanoHAB exposure cases reported from 2010 to 2022, including symptomatic exposure cases with and without clinical effects related to the exposure and asymptomatic exposure cases. We assessed demographics; exposure routes, locations, chronicity; clinical effects; and medical outcomes. We calculated case rates annually and 13-year case rates by US geographic division. Over half of cyanoHAB exposure cases were children < 20 years old (n = 2175). Most cyanoHABs exposures occurred in a "public area" (n = 2902, 68.1%); most were acute (≤ 8 h) (n = 3824, 89.8%). Dermal and ingestion routes and gastrointestinal effects predominated. 2% (n = 102) of cases experienced a moderate or major medical outcome; no deaths were reported. National rates increased from 0.4 cases/1 million (1 M) person-years in 2010 to 1.4 cases/1 M person-years in 2022. The Mountain division had the highest 13-year rate (7.8 cases/1 M person-years). CyanoHAB exposure case rates increased 2010-2022, despite a decrease in all-cause exposure cases during the same period. NPDS data provide valuable public health information for characterization of cyanoHAB exposures, an emerging public health challenge.

Sections du résumé

BACKGROUND BACKGROUND
Harmful algal bloom occurrences have been increasingly reported globally and over time. Exposure to the variety of toxins and co-contaminants that may be present in harmful algal blooms can cause illness and even death. Poison control data is a valuable public health information source that has been used to characterize many types of toxin exposures, including harmful algal blooms. Prior studies have been limited by location and time, and knowledge gaps remain regarding cyanobacteria harmful algal bloom (cyanoHAB) exposure circumstances, and the breadth and severity of associated clinical effect.
METHODS METHODS
The objective of this study was to characterize epidemiologic and clinical features of cyanoHAB exposure cases reported to 55 US poison control centers and available in the National Poison Data System (NPDS). We identified 4260 NPDS cyanoHAB exposure cases reported from 2010 to 2022, including symptomatic exposure cases with and without clinical effects related to the exposure and asymptomatic exposure cases. We assessed demographics; exposure routes, locations, chronicity; clinical effects; and medical outcomes. We calculated case rates annually and 13-year case rates by US geographic division.
RESULTS RESULTS
Over half of cyanoHAB exposure cases were children < 20 years old (n = 2175). Most cyanoHABs exposures occurred in a "public area" (n = 2902, 68.1%); most were acute (≤ 8 h) (n = 3824, 89.8%). Dermal and ingestion routes and gastrointestinal effects predominated. 2% (n = 102) of cases experienced a moderate or major medical outcome; no deaths were reported. National rates increased from 0.4 cases/1 million (1 M) person-years in 2010 to 1.4 cases/1 M person-years in 2022. The Mountain division had the highest 13-year rate (7.8 cases/1 M person-years).
CONCLUSIONS CONCLUSIONS
CyanoHAB exposure case rates increased 2010-2022, despite a decrease in all-cause exposure cases during the same period. NPDS data provide valuable public health information for characterization of cyanoHAB exposures, an emerging public health challenge.

Identifiants

pubmed: 39369221
doi: 10.1186/s12940-024-01121-y
pii: 10.1186/s12940-024-01121-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

80

Informations de copyright

© 2024. The Author(s).

Références

Hanna-Attisha M, LaChance J, Sadler RC, et al. Elevated blood lead levels in children Associated with the Flint drinking Water Crisis: a spatial analysis of risk and Public Health Response. Am J Public Health. 2016;106:283–90. https://doi.org/10.2105/AJPH.2015.303003 .
doi: 10.2105/AJPH.2015.303003
Carmichael WW, Boyer GL. Health impacts from cyanobacteria harmful algae blooms: implications for the North American Great Lakes. Harmful Algae. 2016;54:194–212. https://doi.org/10.1016/j.hal.2016.02.002 .
doi: 10.1016/j.hal.2016.02.002
Paerl HW, Huisman J. Climate change: a catalyst for global expansion of harmful cyanobacterial blooms. Environ Microbiol Rep. 2009;1:27–37. https://doi.org/10.1111/j.1758-2229.2008.00004.x .
doi: 10.1111/j.1758-2229.2008.00004.x
Facts about Cyanobacterial Blooms for Poison Center Professionals | CDC. 2022. https://www.cdc.gov/habs/materials/factsheet-cyanobacterial-habs.html . Accessed February 8, 2024.
Stewart I, Webb PM, Schluter PJ, et al. Recreational and occupational field exposure to freshwater cyanobacteria–a review of anecdotal and case reports, epidemiological studies and the challenges for epidemiologic assessment. Environ Health. 2006;5:6. https://doi.org/10.1186/1476-069X-5-6 .
doi: 10.1186/1476-069X-5-6
Carmichael WW, Lau S, Rinehart KL, et al. Human fatalities from Cyanobacteria: Chemical and Biological evidence for cyanotoxins. Environ Health Perspect. 2001;109(7):663–8. https://doi.org/10.1289/ehp.01109663 .
doi: 10.1289/ehp.01109663
Hilborn ED, Beasley VR. One health and Cyanobacteria in Freshwater systems: animal illnesses and Deaths Are Sentinel Events for Human Health Risks. Toxins (Basel). 2015;7(4):1374–95. https://doi.org/10.3390/toxins7041374 .
doi: 10.3390/toxins7041374
Hardy FJ, Preece E, Backer L. Status of state cyanoHAB outreach and monitoring efforts, United States. Lake Reserv Manag. 2021;37(3):246–60. https://doi.org/10.1080/10402381.2020.1863530 .
doi: 10.1080/10402381.2020.1863530
Harmful Algal Bloom Monitoring System. NCCOS Coastal Science Website. https://coastalscience.noaa.gov/science-areas/stressor-impacts-mitigation/hab-monitoring-system/ . Accessed February 22, 2023.
US EPA. Cyanobacteria Assessment Network Application (CyAN app). 2019. https://www.epa.gov/water-research/cyanobacteria-assessment-network-application-cyan-app . Accessed February 9, 2024.
One Health Harmful Algal Bloom System (OHHABS) | Harmful Algal Blooms | CDC. 2021. https://www.cdc.gov/ohhabs/data/summary-report-united-states-2021.html . Accessed January 23, 2024.
Lavery AM. 2017–2019. MMWR Morb Mortal Wkly Rep. 2021;70:1191–4. https://doi.org/10.15585/mmwr.mm7035a2 . Evaluation of Syndromic Surveillance Data for Studying Harmful Algal Bloom-Associated Illnesses — United States.
OHHABS case and event definitions Table 2018. https://www.cdc.gov/habs/pdf/ohhabs-case-and-event-definitions-table.pdf . Accessed November 6, 2023.
Gummin DD, Mowry JB, Beuhler MC et al. 2021 Annual Report of the National Poison Data System © (NPDS) from America’s Poison Centers: 39th Annual Report. Clinical Toxicology 2022;60(12):1381–1643. https://doi.org/10.1080/15563650.2022.2132768
NPDS. Coding Users’ Manual© Version 4.4.3. 2023.
Carpenter JE, Chang AS, Bronstein AC, et al. Identifying Incidents of Public Health Significance Using the National Poison Data System, 2013–2018. Am J Public Health. 2020;110(10):1528–31. https://doi.org/10.2105/AJPH.2020.305842 .
doi: 10.2105/AJPH.2020.305842
Greene SC, Folt J, Wyatt K, et al. Epidemiology of fatal snakebites in the United States 1989–2018. Am J Emerg Med. 2021;45:309–16. https://doi.org/10.1016/j.ajem.2020.08.083 .
doi: 10.1016/j.ajem.2020.08.083
Beuhler MC, Spiller HA, Alwasiyah D, et al. Adverse effects associated with bupropion therapeutic errors in adults reported to four United States poison centers. Clin Toxicol. 2022;60(5):623–7. https://doi.org/10.1080/15563650.2021.2002353 .
doi: 10.1080/15563650.2021.2002353
Lavery AM, Kieszak SM, Law R, et al. Harmful algal Bloom exposures Self-reported to Poison Centers in the United States, May–October 2019. Public Health Rep. 2023;138(6):865–9. https://doi.org/10.1177/00333549221146654 .
doi: 10.1177/00333549221146654
French BW, Kaul R, George J, et al. A Case Series of potential Pediatric Cyanotoxin exposures Associated with Harmful Algal blooms in Northwest Ohio. Infect Dis Rep. 2023;15(6):726–34. https://doi.org/10.3390/idr15060065 .
doi: 10.3390/idr15060065
Lin CJ, Wade TJ, Sams EA, et al. A prospective study of Marine Phytoplankton and reported illness among recreational beachgoers in Puerto Rico, 2009. Environ Health Perspect. 2016;124(4):477–83. https://doi.org/10.1289/ehp.1409558 .
doi: 10.1289/ehp.1409558
Bureau UC, Geographic, Levels. Census.gov. https://www.census.gov/programs-surveys/economic-census/guidance-geographies/levels.html . Accessed January 22, 2024.
Bureau UC. ACS Demographic and Housing Estimates. https://www.data.census.gov/table/ ACSDP1Y2022.DP05. Accessed May 9, 2024.
O’Donoghue AJ. Effects of algal blooms continue to spread throughout Wasatch Front. Deseret News. https://www.deseret.com/2016/7/19/20592475/effects-of-algal-blooms-continue-to-spread-throughout-wasatch-front . Published July 19, 2016. Accessed November 3, 2023.
Bloch RA, Faulkner G, Hilborn ED, et al. Geographic Variability, Seasonality, and increase in ASPCA Animal Poison Control Center Harmful Blue-Green Algae Calls—United States and Canada, 2010–2022. Toxins. 2023;15(8):505. https://doi.org/10.3390/toxins15080505 .
doi: 10.3390/toxins15080505
Lévesque B, Gervais M-C, Chevalier P, et al. Prospective study of acute health effects in relation to exposure to cyanobacteria. Sci Total Environ. 2014;466–467:397–403. https://doi.org/10.1016/j.scitotenv.2013.07.045 .
doi: 10.1016/j.scitotenv.2013.07.045
DeFlorio-Barker S, Arnold BF, Sams EA, et al. Child environmental exposures to water and sand at the beach: findings from studies of over 68,000 subjects at 12 beaches. J Expo Sci Environ Epidemiol. 2018;28(2):93–100. https://doi.org/10.1038/jes.2017.23 .
doi: 10.1038/jes.2017.23
Hilborn ED, Roberts VA, Backer L, et al. Algal bloom-associated disease outbreaks among users of freshwater lakes–United States, 2009–2010. MMWR Morb Mortal Wkly Rep. 2014;63(1):11–5.
Wu J, Hilborn ED, Schaeffer BA, et al. Acute health effects associated with satellite-determined cyanobacterial blooms in a drinking water source in Massachusetts. Environ Health. 2021;20(1):83. https://doi.org/10.1186/s12940-021-00755-6 .
doi: 10.1186/s12940-021-00755-6
Stewart I, Webb PM, Schluter PJ, et al. Epidemiology of recreational exposure to freshwater cyanobacteria–an international prospective cohort study. BMC Public Health. 2006;6:93. https://doi.org/10.1186/1471-2458-6-93 .
doi: 10.1186/1471-2458-6-93
Backer LC, Carmichael W, Kirkpatrick B, et al. Recreational exposure to low concentrations of Microcystins during an Algal Bloom in a small Lake. Mar Drugs. 2008;6(2):389–406. https://doi.org/10.3390/md20080018 .
doi: 10.3390/md20080018
Lad A, Breidenbach JD, Su RC, et al. As we drink and breathe: adverse Health effects of Microcystins and other Harmful Algal Bloom Toxins in the liver, gut, lungs and Beyond. Life (Basel). 2022;12(3):418. https://doi.org/10.3390/life12030418 .
doi: 10.3390/life12030418
Weirich CA, Miller TR. Freshwater harmful algal blooms: toxins and children’s health. Curr Probl Pediatr Adolesc Health Care. 2014;44(1):2–24. https://doi.org/10.1016/j.cppeds.2013.10.007 .
doi: 10.1016/j.cppeds.2013.10.007
Li H, Barber M, Lu J, et al. Microbial community successions and their dynamic functions during harmful cyanobacterial blooms in a freshwater lake. Water Res. 2020;185:116292. https://doi.org/10.1016/j.watres.2020.116292 .
doi: 10.1016/j.watres.2020.116292
Lee J, Lee S, Hu C, et al. Beyond cyanotoxins: increased Legionella, antibiotic resistance genes in western Lake Erie water and disinfection-byproducts in their finished water. Front Microbiol. 2023;14:1233327. https://doi.org/10.3389/fmicb.2023.1233327 .
doi: 10.3389/fmicb.2023.1233327

Auteurs

Rebecca A Bloch (RA)

College of Veterinary Medicine, Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC, 27606, USA.

Michael C Beuhler (MC)

North Carolina Poison Control, Atrium Health, Charlotte, NC, 28208, USA.
School of Medicine, Wake Forest University, Atrium Health , Charlotte, United States.

Elizabeth D Hilborn (ED)

Center for Public Health and Environmental Assessment, Office of Research and Development, United States Environmental Protection Agency, Chapel Hill, NC, 27514, USA.

Grace Faulkner (G)

College of Veterinary Medicine, Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC, 27606, USA.

Sarah Rhea (S)

College of Veterinary Medicine, Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC, 27606, USA. skrhea@ncsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH